Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
3/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$451M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 6 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -296%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 6 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $319.0M 100.0% | $510.7M 100.0% | $502.4M 100.0% | $640.3M 100.0% | $544.5M 100.0% | $60.3M 100.0% |
| Cost of Revenue | $281.1M 88.1% | $389.6M 76.3% | $378.9M 75.4% | $631.9M 98.7% | $305.6M 56.1% | $50.9M 84.4% |
| Gross Profit | $37.9M 11.9% | $121.1M 23.7% | $123.5M 24.6% | $8.4M 1.3% | $238.9M 43.9% | $9.4M 15.6% |
| Research & Development | — | $11.8M 2.3% | $7.2M 1.4% | $27.0M 4.2% | $7.7M 1.4% | $5.3M 8.7% |
| Selling, General & Admin | $159.2M 49.9% | $113.7M 22.3% | $108.1M 21.5% | $213.3M 33.3% | $60.5M 11.1% | $14.6M 24.1% |
| Total Operating Expenses | — | — | — | $253.0M 39.5% | $72.2M 13.3% | $21.6M 35.8% |
| Operating Income | -$245.6M -77.0% | -$142.1M -27.8% | $9.0M 1.8% | -$2.11B -329.5% | $131.5M 24.2% | -$6.3M -10.5% |
| Interest & Investment Income | — | — | — | — | $35K 0.0% | — |
| Other Income (Expense), net | -$42.4M -13.3% | -$1.29B -253.6% | -$254.8M -50.7% | -$53.9M -8.4% | -$68.4M -12.6% | -$5.9M -9.7% |
| Pretax Income | -$288.0M -90.3% | -$1.44B -281.4% | -$245.8M -48.9% | -$2.16B -337.9% | $63.1M 11.6% | -$12.2M -20.2% |
| Income Tax Expense | $583K 0.2% | $859K 0.2% | $683K 0.1% | -$17.1M -2.7% | $15.8M 2.9% | $0 0.0% |
| Net Income | -$288.6M -90.5% | -$1.44B -281.6% | -$246.5M -49.1% | -$2.15B -335.2% | $47.3M 8.7% | -$12.2M -20.2% |
| Per Share | ||||||
| EPS (Basic) | $-0.88 | $-4.87 | $-0.65 | $-6.30 | $0.23 | $-0.14 |
| EPS (Diluted) | $-0.88 | $-4.87 | $-0.65 | $-6.30 | $0.20 | $-0.14 |
| Weighted Avg Shares (Basic) | 318.1M | 255.8M | 379.9M | 340.6M | 207.3M | 157.6M |
| Weighted Avg Shares (Diluted) | 318.1M | 255.8M | 379.9M | 340.6M | 233.3M | 157.6M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash of $311M fully covers short-term debt of $0.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
No current price collected.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cost of Revenue | 84.4 | 56.1 | 98.7 | 75.4 | 76.3 | 88.1 |
| Gross Profit | 15.6 | 43.9 | 1.3 | 24.6 | 23.7 | 11.9 |
| R&D | 8.7 | 1.4 | 4.2 | 1.4 | 2.3 | — |
| SG&A | 24.1 | 11.1 | 33.3 | 21.5 | 22.3 | 49.9 |
| Operating Income | -10.5 | 24.2 | -329.5 | 1.8 | -27.8 | -77.0 |
| Income Tax | 0.0 | 2.9 | -2.7 | 0.1 | 0.2 | 0.2 |
| Net Income | -20.2 | 8.7 | -335.2 | -49.1 | -281.6 | -90.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CORZW: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position